In CRC patients, a high infiltration of FOXP3+ cells has been linked to an improved prognosis [17, 18], which is in contrast to what has been shown for many other cancer types e.g. renal cancer and breast cancer [19]. The gene discussed is FOXP3; the disease is breast cancer.